Related Products
Esophagus carcinoma (15 cases), with NAT.
131
$1,004.50
Esophagus carcinoma (15 cases), with NAT.
131-HEsoS045Ly01-GEN
Esophagus carcinoma (43 cases), and NAT.
131
$1,323.00
Esophagus carcinoma (43 cases), and NAT.
131-HEso-Squ060CD-01-GEN
Hepatocellular carcinoma, 90 cases. Tumor and NAT.
131
$6,037.50
Hepatocellular carcinoma, 90 cases. Tumor and NAT.
131-HLivH180Su07-GEN
Esophagus carcinoma (15 cases), tumor and NAT.
131
$829.50
Esophagus carcinoma (15 cases), tumor and NAT.
131-HEsoS030PG04-GEN
30 cases of pancreatic carcinoma and matched NAT.
131
$1,158.50
30 cases of pancreatic carcinoma and matched NAT.
131-HPan-Dis060PT-01-GEN
Hepatocellular carcinoma, 32 cases. Tumor and NAT.
131
$2,156.00
Hepatocellular carcinoma, 32 cases. Tumor and NAT.
131-HLivH070Su01-GEN
Hepatocellular carcinoma, 49 cases. Tumor and NAT.
131
$2,142.00
Hepatocellular carcinoma, 49 cases. Tumor and NAT.
131-HLivHCC180Bch01-GEN
Lung carcinoma,92 cases, tumor and matched NAT.
131
$5,484.50
Lung carcinoma,92 cases, tumor and matched NAT.
131-HLugA180Su03-GEN
esophagus carcinoma,100 cases, tumor and matched NAT.
131
$490.00
esophagus carcinoma,100 cases, tumor and matched NAT.
131-HEsoS180Su04-GEN